ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

CDXS Codexis Inc

3,95
0,61 (18,26%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Codexis Inc CDXS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,61 18,26% 3,95 06:00:14
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,62 3,53 4,01 3,92 3,34
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202422:05GLOBECodexis Reports First Quarter 2024 Financial Results
18.4.202422:05GLOBECodexis to Report First Quarter 2024 Financial Results on..
11.4.202413:05GLOBECodexis Appoints Carole Cobb, MBA, to Strategic Advisory..
06.3.202422:02EDGAR2Form 8-K - Current report
28.2.202422:05GLOBECodexis Reports Fourth Quarter and Fiscal Year 2023..
27.2.202418:15APSBiotech Rallied Strongly On Exclusive Licensing Agreement
26.2.202422:05GLOBECodexis Enters Exclusive Licensing Agreement for Newly..
26.2.202414:05GLOBECodexis to Participate in TD Cowen 44th Annual Health Care..
20.2.202414:05GLOBECodexis Announces Appointment of Masad Damha, PhD, and Jim..
16.2.202422:01EDGAR2Form 8-K - Current report
14.2.202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202422:05GLOBECodexis to Report Fourth Quarter and Fiscal Year 2023..
13.2.202422:19EDGAR2Form 8-K - Current report
13.2.202422:05GLOBECodexis Secures $40 Million in Strategic Financing Deal with..
09.2.202422:06EDGAR2Form 8-K - Current report
01.2.202422:05GLOBEseqWell and Codexis to Unveil Engineered Transposase Enzyme..
24.1.202420:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.1.202414:30EDGAR2Form 8-K - Current report
03.1.202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.1.202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202314:30GLOBECodexis Announces Purchase Agreement with Nestlé Health..
27.12.202314:30EDGAR2Form 8-K - Current report
13.12.202322:06GLOBECodexis and Aldevron Enter Exclusive Licensing Agreement for..
13.12.202322:05GLOBECodexis Announces Achievement of Gram-scale Synthesis with..
11.12.202313:05GLOBECodexis KOL Event Highlights Significant Need for an..
28.11.202322:05GLOBECodexis to Host Virtual KOL Event on its ECO Synthesis™..
17.11.202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202323:31EDGAR2Form 144 - Report of proposed sale of securities
14.11.202322:05GLOBECodexis to Participate in 35th Annual Piper Sandler..
03.11.202321:26EDGAR2Form 8-K/A - Current report: [Amend]
03.11.202321:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:16EDGAR2Form 8-K - Current report
02.11.202321:05GLOBECodexis Reports Third Quarter 2023 Financial Results
31.10.202321:05GLOBECodexis to Participate in Upcoming Healthcare Conferences
27.10.202321:35GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
26.10.202322:05GLOBECodexis to Present Update on ECO Synthesis™ Platform at..
19.10.202322:05GLOBECodexis to Report Third Quarter 2023 Financial Results on..
29.9.202313:05GLOBECodexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton..
22.9.202322:32EDGAR2Form 8-K - Current report
18.9.202322:05GLOBECodexis CEO Stephen Dilly Named as Finalist of 2023 Bloom..
12.9.202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.9.202322:05GLOBECodexis to Participate in Cantor Global Healthcare..
07.9.202322:05EDGAR2Form 8-K - Current report
07.9.202322:05GLOBECodexis Announces Agreement for Assignment and Assumption of..
03.8.202322:54EDGAR2Form S-8 - Securities to be offered to employees in employee..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock